Intelligent and Programmable Nanomaterials for Medicine

A special issue of Journal of Clinical Medicine (ISSN 2077-0383).

Deadline for manuscript submissions: closed (20 September 2018)

Special Issue Editors

Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
Interests: biomedical engineering; biomimetic nanomaterials; nanotechnology; nanoparticles drug delivery; biomaterials; nanomedicine; nanobiotechnology; microphysiological systems
Case Western Reserve University, Cleveland, OH, USA
Interests: biomedical engineering; viral nanoparticles; nanomedicine; vaccines; immunotherapy; immune modulation; drug delivery

Special Issue Information

Dear Colleagues,

Over the past few decades, the field of intelligent and programmable nanomaterials has been rapidly transforming. Integrating insights from chemistry, materials science, and engineering with biomedical and clinical needs has given rise to innovative advances and unprecedented control over nanomaterial tunability.

Biomimetic nanomaterials can be designed and modified for superior functionalities, such as for the fabrication of multivalent particles with enhanced targeting specificity. Additionally, an amazing array of advanced nanomaterials can be created to respond to a variety of stimuli, both internal (e.g., pH, redox potential, enzyme activity, shear) and external (e.g., light, heat, magnetic field, ultrasound). By using such triggers to modulate the conformation or phase transition of nanomaterials, exquisite spatial and temporal control can be achieved. In fact, novel stimulus-responsive formulations have been integrated into diagnostics and drug delivery complexes that are currently in clinical trials or being commercialized (e.g., ThermoDox® liposomes and glucose biosensors).

Advancements in this field continue to expand quickly, with new medical technologies covering a broad scope of applications, such as surface coatings for inhibition of biofilm formation and stealth nanoparticles for safer and more efficient drug delivery.

We hope that you will join us for this exciting Special Issue to present the latest developments in the invention, manipulation, and implementation of intelligent and programmable nanomaterials for applications in medicine.

Dr. Amy M. Wen
Dr. Sourabh Shukla
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Smart nanomaterials
  • Stimulus-responsive materials
  • Nanotechnology
  • Surface functionalization
  • Stealth
  • Targeted delivery
  • Diagnostics
  • Theranostics

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop